Gene and Genome Editing technologies have revolutionized the field of molecular biology, offering powerful tools for precise manipulation of genetic material. Through these techniques, scientists can modify DNA sequences with unprecedented accuracy, enabling targeted alterations in genes and entire genomes. Gene editing involves the direct modification of specific genes within an organism's genome, while genome editing encompasses broader modifications spanning entire genomes. The advent of clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated protein 9 (Cas9) has particularly catalyzed advancements in gene and genome editing, providing researchers with versatile and efficient platforms for genetic engineering. These molecular scissors allow for precise DNA cleavage at targeted locations, facilitating gene knockout, insertion, and modification with remarkable precision. Moreover, CRISPR-based technologies have expanded beyond traditional model organisms, enabling genome editing in a wide range of species, including plants, animals, and even humans. Gene and genome editing hold immense promise for biomedical applications, including the treatment of genetic disorders, cancer therapy, and personalized medicine. Additionally, these technologies have transformative implications for agriculture, enabling the development of crops with enhanced traits such as disease resistance, nutritional value, and yield. However, alongside their tremendous potential, gene and genome editing also raise ethical and safety considerations, particularly regarding off-target effects and unintended consequences.
Title : Biotech innovations: Bioengineering potential for novel biomanufacturing systems
Murray Moo Young, University of Waterloo, Canada
Title : Targeting noncanonical epitopes in anti-cancer immunotherapy
Michele Mishto, Francis Crick Institute, United Kingdom
Title : Eliminating implant infection: 30,000 nanotextured implants in humans with no failure
Thomas J Webster, Interstellar Therapeutics, United States
Title : Stem cell therapy: An affordable healthcare therapy for various diseases
Anant Marathe, Total Potential Cells (P) Ltd, India
Title : Information leakage: Types, remedies, and open problems
Julia Sidorova, Centro de Investigación Biomédica En Red Enfermedades Hepáticas y Digestivas (CIBEREHD), Spain
Title : Development and characterization of exo-ITC: A fibrous bilayer exosome delivery system for dermatological applications
Luis Jesus Villarreal Gomez, Universidad Autonoma de Baja California, Mexico